Molecular Subtypes As Emerging Predictors of Clinicopathological Response to Neoadjuvant Chemotherapy (NACT) in Locally Advanced Breast Cancer (LABC): A Single-Centre Experience in Western India-Reference-Cited by-同舟云学术

Molecular Subtypes As Emerging Predictors of Clinicopathological Response to Neoadjuvant Chemotherapy (NACT) in Locally Advanced Breast Cancer (LABC): A Single-Centre Experience in Western India

Published:2022-05-22 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Sharma Sarthak,Rathore Shaitan Singh,Verma Vijay,Kalyan Murlidhar,Singh Narender,Irshad Irshad

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference24 articles.

1. Global patterns of breast cancer incidence and mortality: a population-based cancer registry data analysis from 2000 to 2020;Lei S;Cancer Commun,2021

2. Definition of LABC. (2022). Accessed. April 24, 2022: http://cancerindia.org.in/cancer-statistics/.

3. Breast cancer version 2.2015;Gradishar WJ;J Natl Compr Canc Netw,2015

4. Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer;Kim SI;Oncology,2010

5. Survival of women with locally advanced breast cancer at a teaching hospital in Lahore;Iqbal J;J Pak Med Assoc,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of targeted axillary dissection in node positive locally advanced breast cancer patients with complete pathological response to neoadjuvant chemotherapy;The Egyptian Journal of Surgery;2024-03-22

2. <i>TP53</i> Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy;Breast Care;2024

3. Development and Validation of an Interpretable Machine Learning Prediction Model for Total Pathological Complete Response after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: Multicenter Retrospective Analysis;Journal of Cancer;2024

4. Predictive value of acoustic radiation force impulse imaging in breast cancer after neoadjuvant chemotherapy;Biotechnology and Genetic Engineering Reviews;2023-03-21